Latest News
April 27, 2022 | Broad Stem Cell Research Center Member Spotlight: April Pyle’s journey from scientist to startup co-founder
Meet April Pyle, PhD, professor and co-founder of MyoGene Bio, a biotech company that’s developing a new gene therapy for Duchenne muscular dystrophy, a deadly genetic condition that largely affects boys. Here, she talks about how the collaborative environment at UCLA...
April 27, 2022 | CNSI launches three-part program to prepare students for entry into the California workforce
The California NanoSystems Institute at UCLA, also known as CNSI, is launching a three-part program, with support from the state of California, to enhance student engagement with industry partners and address the need for training that aligns with the needs of...
March 29, 2022 | Q&A with Dr. Gay Crooks: “5 Questions With”
In celebration of Women’s History Month and in preparation for the upcoming LA Best Bioscience Ecosystem Summit this spring, we spoke with Dr. Gay Crooks about her research at UCLA, her quest to change the way cancer is treated and her love of Los Angeles as a great ecosystem for science.
January 27, 2022 | Bluefin Foods creates a better solution to supply the world with cell-cultured seafood and meat
Bluefin Foods Inc., which is part of the Magnify incubator at the California NanoSystems Institute at UCLA (CNSI) is a cell-cultured seafood company focused on bringing bluefin tuna sushi products to all the sushi lovers in the world. ...
January 24, 2022 | UCLA Spinout Concrete-AI Closes $2M Seed Round for Concrete Efficiency Platform
Concrete-AI was founded early last year to commercialize technology developed at UCLA’s Institute for Carbon Management by Gaurav Sant and Mathieu Bauchy. Sant and Bauchy are faculty members in UCLA’s Samueli School of Engineering in the departments of civil and...
January 5, 2021 | Octant continues pursuit of drug discovery
Octant, known for the company’s contribution of SwabSeq sequencing technology to the campus’s covid testing vending machines, graduated from the CNSI’s Magnify incubator. Co-founded by Sri Kosuri, an associate professor in the chemistry and biochemistry department,...
December 15, 2021 | Gene therapy start-up secures $3.4 million award from California stem cell agency
Los Angeles–based start-up MyoGene Bio has received a $3.4 million grant from the California Institute for Regenerative Medicine (CIRM) through its Translational Research Program, meant to accelerate the investigations needed to translate stem cell-based approaches...
December 2, 2021 | CIRM grants support promising stem cell-based projects; include two CNSI Magnify incubator start-ups
The California Institute for Regenerative Medicine recently approved a $44.1 million investment in 11 projects as part of the Translational Research Program (TRAN). The awardees include two start-up companies from the Magnify incubator at CNSI, MyoGene Bio and...
August 5, 2021 | Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer
Kite, a Gilead Company (Nasdaq: GILD), and Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, today announced a collaboration and license agreement to research...